J D Minna

Southwestern Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

41h-index11.2kcitations68works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(15), Lung Cancer Treatments and Mutations(14), Cancer Genomics and Diagnostics(12), Lung Cancer Research Studies(12), Epigenetics and DNA Methylation(11)

Publications68 total

A Lung Cancer Mouse Model Database
2024· 1 citedOpen Access
P71.02 Estrogen Promotes Resistance to Bevacizumab Treatment in Non-Small Cell Lung Cancer (NSCLC) Xenograft Models
Journal of Thoracic Oncology·2021Open Access
P3.03-007 LCMC2: Expanded Profiling of Lung Adenocarcinomas Identifies ROS1 and RET Rearrangements and TP53 Mutations as a Negative Prognostic Factor
Journal of Thoracic Oncology·2017
Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies
Annals of Oncology·2017· 107 citedOpen Access
LZTFL1 suppresses lung tumorigenesis by maintaining differentiation of lung epithelial cells
Oncogene·2015· 57 citedOpen Access
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer
Oncogene·2013· 82 citedOpen Access
Precision Medicine for Cancer Patients: Lessons Learned and the Path Forward
JNCI Journal of the National Cancer Institute·2013· 13 citedOpen Access
552 Comprehensive Genomic Profiling of Small Cell Lung Cancer Reveals SOX2 Amplification and MYCL1 Rearrangements
European Journal of Cancer·2012
257 BRG1-Inactivating Mutations as Potential Predictive Markers for Aurora Kinase A-Targeted Therapy
European Journal of Cancer·2012
Defining Molecular and Cellular Responses after Low and High Linear Energy Transfer Radiations to Develop Biomarkers of Carcinogenic Risk or Therapeutic Outcome
Health Physics·2012· 8 cited
609 Integrative analysis of DNA methylation and gene expression identifies a DNA methylation signature associated with erlotinib resistance in EGFR wild type non-small cell lung cancer cells
European Journal of Cancer Supplements·2010
Multifocal Lung Cancers--Clonality vs Field Cancerization and Does It Matter?
JNCI Journal of the National Cancer Institute·2009· 118 citedOpen Access
ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia
Oncogene·2005· 69 citedOpen Access
O-016 Whole genome comparison of SCLC and NSCLC cells identifies novel signature genetic alterations
Lung Cancer·2005
P-072 Gene expression profiling in lung adenocarcinomas revealsmolecular signatures with respect to gender, smoking, tumor grading and disease-free survival
Lung Cancer·2005
O-011 Gene mutations indicate different pathways to lung cancers innever and ever smokers
Lung Cancer·2005
P-025 Fine mapping of SCLC tumors and cell lines by high resolutionarray CGH identifies novel alterations
Lung Cancer·2005
Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
JNCI Journal of the National Cancer Institute·2005· 2.4k cited
Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features.
PubMed·2001· 423 cited
High-Resolution Chromosome 3p Allelotyping of Breast Carcinomas and Precursor Lesions Demonstrates Frequent Loss of Heterozygosity and a Discontinuous Pattern of Allele Loss
American Journal Of Pathology·2001· 149 cited
page 1 of 4Next →

Frequent Co-authors

Adi F. Gazdar(13), A K Virmani(10), Adi F. Gazdar(9), Ignacio I. Wistuba(8), Kwun M. Fong(6), Sara Milchgrub(6), A F Gazdar(6), Yoshitaka Sekido(5), David P. Carbone(5), Marion M. Nau(4), Shinichi Toyooka(3), Sabine Zöchbauer‐Müller(3), Farida Latif(3), Takashi Takahashi(3), Carmen Behrens(3), Bruce E. Johnson(3), Hiltrud Brauch(3), B. Zbar(3), Adi F. Gazdar(2), Monja L. Proctor(2)